Picofemto, a biomedical software company specializing in neuroanalytics and personalized medicine, has announced the deployment of its first product, EEG decision support, based on its proprietary cloud-based biomedical engine, Cliniscan.
Cliniscan, the web-based software as a service (SaaS) platform, provides rapid analysis of complex biomedical data to support clinical decisions by physicians.
In addition, Picofemto’s open-standards base design emphasizes security, anonymity, and trust, while enabling partnerships for third party diagnostic algorithms with its dynamic open API.
The easy-to-use-web interface addresses the medical community and removes the burden of data manipulation and storage while enhancing interoperability for the physician and the patient.
The product immediately benefits healthcare professionals and institutions, particularly in the neurology field, by providing software that integrates multiple biomedical modalities (EEG, MRI, CT), into a single package that can efficiently process complex data – including quantitative EEG analysis and brain segmentation.
Additionally, Cliniscan will permit the storage, retrieval, and sharing of digital biomedical files, including DICOM.
Cliniscan COO Kai Matsumiya said: "This technology will lower healthcare costs by decreasing both time and cost while increasing efficiency."
The core of the Cliniscan platform is a custom engine that divides workloads dynamically across a number of computing nodes.
This greatly reduces the time required to analyze data sets and to run workflows that are beyond the capabilities of desktop systems.